Whois & Analysis for mysymbicort.com

Budesonide/formoterol is a combination formulation containing budesonide and formoterol used in the management of asthma and chronic obstructive pulmonary disease (COPD).

It contains two active ingredients delivered via a single inhaler:

Asthma is a common long term inflammatory disease of the airways of the lungs.

It is characterized by variable and recurring symptoms, reversible airflow obstruction, and bronchospasm.

Symptoms include episodes of wheezing, coughing, chest tightness, and shortness of breath.

These episodes may occur a few times a day or a few times per week.

Depending on the person they may become worse at night or with exercise.

Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term poor airflow.

The main symptoms include shortness of breath and cough with sputum production.

COPD is a progressive disease, meaning it typically worsens over time.

Eventually everyday activities, such as walking up stairs, become difficult.

Chronic bronchitis and emphysema are older terms used for different types of COPD.

The term "chronic bronchitis" is still used to define a productive cough that is present for at least three months each year for two years.

An inhaler (or puffer) is a medical device used for delivering medication into the body via the lungs.

It is mainly used in the treatment of asthma and chronic obstructive pulmonary disease.

Zanamivir, used to treat influenza, must be administered via inhaler.

Fumaric acid or trans-butenedioic acid is the chemical compound with the formula HO2CCH=CHCO2H.

This white crystalline compound is one of two isomeric unsaturated dicarboxylic acids, the other being maleic acid.

In fumaric acid the carboxylic acid groups are trans (E) and in maleic acid they are cis (Z).

Fumaric acid has a fruit-like taste.